Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study

Leprosy Review

Volumn 72, Issue 2, 2001, Pages 179-191

  Wakhlu, A ^a,c   Gaur, S P S ^b   Kaushal, G P ^a   Misra, Arvind ^a   Asthana, O P ^b   Sircar, A R ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; LEPROMIN; LEPROSY VACCINE; MYCOBACTERIUM HABANA VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOUSEHOLD; HUMAN; IMMUNE RESPONSE; INJECTION SITE; JAUNDICE; LEPROMATOUS LEPROSY; LIVER FUNCTION TEST; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; MYCOBACTERIUM HABANA; PAIN; SEROCONVERSION; ULCER;

EID: 0034941554     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.20010024     Document Type: Article

References (22)

1. Anti leprosy vaccines - Field trials and future prospects
2. Antileprosy potentials of the ICRC vaccine. A study in patients and healthy volunteers
3. Randomized control trial of single BCG, repeated BCG or combined BCG and killed M. leprae vaccine for prevention of leprosy and tuberculosis in Malawi
4. Addition of immunotherapy with Mycobacterium w vaccine to multidrug therapy benefits multibacillary leprosy patients
5. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy
6. Immunotherapy with a mixture of M. leprae and BCG in different forms of leprosy and in Mitsuda negative contacts
7. Rationales for vaccines against leprosy
8. Prognostic value of the lepromin test in contacts of leprosy cases
9. Prognostic value of lepromin in contacts of leprosy cases
10. Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana
11. Immunological potential of cultivable mycobacterial strain M. habana against leprosy bacillus in mouse footpad
12. Containment of Mycobacterium leprae multiplication in foot pad of M. habana vaccinated animals
13. Vaccination of mice against M. leprae infection
14. Induction of lepromin positivity in monkeys by a candidate antileprosy vaccine, Mycobacterium habana
15. Lymphostimulatory and delayed-type hypersensitivity responses to a candidate leprosy vaccine strain: Mycobacterium habana
16. The 65 kDa protein of M. habana and its putative role in immunity against experimental tuberculosis
17. A major T-cell inducing cytosolic 23 kDa protein antigen of the vaccine candidate M. habana is superoxide dismutase
18. Post vaccination sensitization with ICRC vaccine
19. Elimination of M. leprae subsequent to in vivo activation of macrophages in lepromatous leprosy by other mycobacteria
20. Notes on some observations about the post lepromin scar
21. Induction of DTH in human volunteers immunized with a candidate leprosy vaccine consisting of killed M. leprae